V3R 3 Inhibitors
Chemical inhibitors of V3R 3 employ various mechanisms to interfere with the protein's function. Staurosporine acts as a broad-spectrum kinase inhibitor, targeting the protein kinases that are essential for the phosphorylation and subsequent activation of V3R 3, as well as its associated signaling proteins. Similarly, Bisindolylmaleimide I achieves inhibition by specifically targeting protein kinase C (PKC), which plays a pivotal role in the phosphorylation processes related to V3R 3. H-89 focuses on protein kinase A (PKA), another kinase which, when inhibited, can prevent the activation sequence of V3R 3 from initiating. LY294002 and Wortmannin both serve as inhibitors of PI3K, a kinase upstream of V3R 3 in the signaling pathway. By halting PI3K activity, these inhibitors obstruct the cascade of events needed for V3R 3's activation and function within the cell.
Further along the signaling pathways, PD98059 and U0126 are employed to inhibit MEK, a kinase within the MAPK/ERK pathway. This inhibition can disrupt the pathway that may be critical for V3R 3 signaling. SB203580 specifically inhibits p38 MAP kinase, which can alter the signaling dynamics involving V3R 3, leading to its functional inhibition. JNK is another target for chemical inhibition by SP600125, which, by preventing the kinase's activity, can stop the activation of V3R 3-related pathways. PP2, an inhibitor of Src family kinases, can interrupt the phosphorylation of various substrates, including those associated with V3R 3, while AG490 targets JAK2 kinase, potentially halting the JAK-STAT signaling that V3R 3 utilizes. Lastly, Gefitinib inhibits EGFR tyrosine kinase, which can play a role in the upstream signaling events necessary for V3R 3 activation, thereby leading to its functional inhibition. These diverse chemical inhibitors collectively target different kinases and pathways, each playing a role in the complex regulation and function of V3R 3.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits a broad spectrum of protein kinases, which could lead to the functional inhibition of V3R 3 by blocking the protein kinases that phosphorylate V3R 3 or its associated signaling proteins, thus preventing its activation and subsequent signal transduction. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I specifically inhibits protein kinase C (PKC), which is involved in the regulation of various receptors. Inhibition of PKC could prevent the phosphorylation and activation of V3R 3, leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K. By blocking PI3K activity, LY294002 could prevent the activation of downstream targets within the PI3K pathway that are involved in the functional regulation of V3R 3, leading to its inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. It can inhibit the PI3K pathway upstream of V3R 3, which could prevent the activation of signaling cascades that V3R 3 is part of, resulting in the functional inhibition of V3R 3. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. Inhibition of MEK could prevent the activation of the ERK pathway, which may be involved in the signaling processes of V3R 3, thereby inhibiting V3R 3 function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 also inhibits MEK, thereby potentially inhibiting the MAPK/ERK pathway and the subsequent activation of V3R 3, leading to its functional inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. Inhibiting p38 MAP kinase could disrupt signaling pathways involving V3R 3, leading to the functional inhibition of the protein. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 selectively inhibits JNK, which could prevent the activation of signaling pathways that involve V3R 3, resulting in its functional inhibition. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family kinases. Src kinases can phosphorylate a range of substrates including receptors. Inhibition of these kinases by PP2 could lead to the functional inhibition of V3R 3 by blocking its associated signaling pathways. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
AG490 inhibits JAK2 kinase, which could prevent the activation of the JAK-STAT signaling pathway that V3R 3 might use for its function. As a result, V3R 3 would be functionally inhibited. | ||||||